Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Thermo Fisher ( (TMO) ).
On October 7, 2025, Thermo Fisher Scientific Inc. issued $2.5 billion in senior notes across four different maturities, with the proceeds intended for general corporate purposes such as acquisitions, debt refinancing, and capital expenditures. The issuance is part of a strategic financial maneuver to strengthen the company’s liquidity and operational flexibility, potentially impacting its market positioning and offering opportunities for growth and investment.
The most recent analyst rating on (TMO) stock is a Buy with a $590.00 price target. To see the full list of analyst forecasts on Thermo Fisher stock, see the TMO Stock Forecast page.
Spark’s Take on TMO Stock
According to Spark, TipRanks’ AI Analyst, TMO is a Outperform.
Thermo Fisher’s overall stock score of 78 reflects its robust financial performance and positive earnings call, which highlight strong operational execution and increased guidance. The technical analysis supports a bullish outlook, though the high valuation and external challenges in certain markets temper the score.
To see Spark’s full report on TMO stock, click here.
More about Thermo Fisher
Thermo Fisher Scientific Inc. operates in the scientific instruments and laboratory equipment industry, providing a wide range of products and services including analytical instruments, laboratory equipment, software, services, consumables, reagents, and chemicals. The company focuses on serving healthcare, life sciences, and industrial markets globally.
Average Trading Volume: 2,526,705
Technical Sentiment Signal: Strong Buy
Current Market Cap: $205.4B
See more insights into TMO stock on TipRanks’ Stock Analysis page.